Do E-series prostaglandins and their metabolites influence oxidation of native and glycated low-density lipoproteins?

Prostaglandins and Other Lipid Mediators

Volumn 55, Issue 1, 1998, Pages 67-76

  Sobal, Grazyna ^a   Menzel, Johannes E ^a   Sinzinger, Helmut ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Glycation; LDL; Oxidized LDL; Prostaglandins

Indexed keywords

13,14 DIHYDRO 15 OXOPROSTAGLANDIN E2; 13,14 DIHYDROPROSTAGLANDIN E1; COPPER SULFATE; LOW DENSITY LIPOPROTEIN; PROSTAGLANDIN E; PROSTAGLANDIN E1; PROSTAGLANDIN E2;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; DIABETIC ANGIOPATHY; ENDOCYTOSIS; FEMALE; FOAM CELL; GLYCATION; HUMAN; LIPID OXIDATION; LIPID TRANSPORT; MALE; NORMAL HUMAN; OXIDATION REDUCTION REACTION; PROSTAGLANDIN METABOLISM; ULTRACENTRIFUGATION;

ADULT; FEMALE; GLUCOSE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PROSTAGLANDINS E;

EID: 0031658368     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(98)00005-7     Document Type: Article

References (28)

1. Kortland W., van Rijn H.J.M., Erkelens D.W. Glycation and lipoproteins. Diab. Nutr. Metab. 6:1993;231-233.
2. Curtis K., Witztum J.L. Plasma apolipoproteins AI, AII, B, CI, and E are glycosylated in hyperglycemic diabetics. Diabetes. 34:(Suppl.):1984;5-7A.
3. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New Engl. J. Med. 318:1988;1315-1318.
4. Esposito C., Gerlach H., Brett J., Stern D., Vlassara H. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J. Exp. Med. 170:1989;1387-1390.
5. Radoff S., Cerami A., Vlassara H. Isolation of surface binding protein for advanced glycosylation end products from mouse macrophage-derived cell line RAW 264.7. Diabetes. 39:1990;1510-1512.
6. 1 and arterial wall lipid metabolism - in-vitro, ex-vivo and in-vivo studies. J. Physiol. Pharmacol. 45:1994;27-40.
7. Douillet C., Chancerelle Y., Cruz C., Maroncles C., Kergonou J.F., Renaud S., et al. High dosage vitamin E effect on oxidative status and serum lipid distribution in streptozotocin-induced diabetic rats. Biochem. Med. Metab. Biol. 50:1993;265-276.
8. Rosenfeld M.E., Khoo J.C., Miller E., Parthasarathy S., Palinski S.W., Witztum J.L. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins and contain oxidation-specific lipid-protein adducts. J. Clin. Invest. 87:1991;90-93.
9. Palinski W., Rosenfeld M.E., Ylä-Herttuala S. LDL undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;137213-137276.
10. Maggi E., Finardi G., Poli M., Bollati P., Filippovi M., Stefano P.L., Paolini G., et al. Specificity of autoantibodies against oxidized low-density lipoprotein as an additional marker for atherosclerotic risk. Coron. Artery Dis. 4:1993;1119-1122.
11. Bucala R., Makita Z., Koschinsky T., Cerami A., Vlassara H. Lipid advanced glycosylation Pathway for lipid oxidation in vivo . Proc. Natl. Acad. Sci. USA. 90:1993;6434-6438.
12. Bowie A., Owens D., Collins P., Johnson A., Tomkin G.H. Glycosylated LDL is more sensitive to oxidation Implications for the diabetic patient? Atherosclerosis. 102:1993;63-67.
13. Sakurai T., Kimura S., Nakano, Kimura H. Oxidative modification of glycated LDL in the presence of iron. Biochem. Biophys. Res. Comm. 177:1991;433-439.
14. Hunt J.V., Smith C.C.T., Wolff S.P. Autooxidative glycosylation and possible involvement of peroxides and free radicals in low-density lipoprotein modification by glucose. Diabetes. 39:1990;1420-1424.
15. Yokode M., Kita T., Kikawa Y., Ogorochi T., Narumiya S., Kawai C. Stimulated arachidonate metabolism during foam cell transformation of mause peritoneal macrophages with oxidized low-density lipoprotein. J. Clin. Invest. 81:1988;720-729.
16. Wheeler D.C., Chana R.S., Topley N., Peterson N.M., Davies M., Williams J.D. Oxidation of low-density lipoprotein by mesangial cells may promote glomelular injury. Kidney Int. 45:1994;1628-1636.
17. Matthys K.E., Van-Hove C.E., Jorens P.G., et al. Dual effects of oxidized low-density lipoprotein on immune-stimulated nitric oxide and prostaglandin realease in macrophages. Eur. J. Pharmacol. 298:1966;97-103.
18. Wolfovitz E., Aviram M., Brook J.G., Tatarsky I., Lanir N. Protective effect of low concentration of oxidized low-density lipoprotein on endothelial cell integrity. J. Cardiovasc. Risk. 2:1995;57-62.
19. Fitscha P., Kaliman J., O'Grady J., Sinzinger H. In vivo modulation of platelet deposition on human atherosclerotic lesions by various antiaggregatory prostaglandins. Folia Haematol. 115:1988;443-446.
20. 2, and mimetics in patients with peripherial vascular disease. Prog. Clin. Biol. Res. 301:1989;85-96.
21. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separeted lipoproteins in human serum. J. Clin. Invest. 34:1985;1345-1353.
22. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoproteins. Free Rad. Res. Comm. 6:1981;67-75.
23. Buege J.A., Aust S.D. Lactoperpxidase-catalyzed lipid peroxidation of microsomal and artifical membranes. Biochim. Biophys. Acta. 444:1976;192-201.
24. Peterson D.A., Kelly B., Mehta N., Gerrard J.M. Prostaglandins are reducing agents A model of adenylate cyclase activation? Prostaglandins. 36:1988;667-671.
25. 1. Biochem. Mol. Biol. Int. 39:1996;1177-1184.
26. Gryglewski R.J., Szczeklik A., Wandzilak M. The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes simulated by zymosan or formyl-methionyl-leucyl-phenylalanine. Biochem. Pharmacol. 36:1987;4209-4213.
27. Sinha A.K., Colman R.W. Inhibition of ADP-induced platelet aggre-gation by reduced factor Xa. Eur. J. Biochem. 136:1983;57-62.
28. 2 alters the metabolism of labeled glucose in uteri isolated from ovariectomized rats. Effects of 17-beta estradiol and indometacin. Prostaglandins Leukot. Essent. Fatty Acids. 35:1989;31-35.